Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity

Clinical and Experimental Rheumatology

Volumn 16, Issue 3, 1998, Pages 289-294

  Incaprera, M ^a   Rindi, L ^a   Bazzichi, A ^a   Garzelli, C ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Autoimmunity; Epstein Barr virus; Molecular mimicry; Systemic lupus erythematosus

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; EPSTEIN BARR VIRUS; HUMAN; IMMUNOGENICITY; IMMUNOPATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS DETECTION; VIRUS INFECTIVITY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFECTIOUS MONONUCLEOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0031982253     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. CHANG RS, GOLDEN HD: Transformation of human lymphocytes by throat washings from infectious mononucleosis patients. J Infect Dis 1971; 243:359-60.
2. SIXBEY JW, NEDRUD JG, RAAB-TRAUB N, HANES RA, PAGANO JS: Epstein-Barr virus replication in oropharyngeal epithelial cells. NEnglJMcd 1984; 310: 1225-30.
3. MOSS DJ, RICKINSON AB, POPE JH: Longterm T-cell mediated immunity to EpsteinBair virus in man. InlJ Cancer 1978; 22:6628.
4. RICKINSON AB, MOSS DJ, POPE JH: Longterm T-cell mediated immunity to EpsteinBarr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. IntJ Cancer 1979; 23: 610-7.
5. TOSATO G, MAGRATH I, KOSKI I, DOOLEY N, BLAESE M: Activation of suppressor T cells during Epstein-Barr virus-induced infectious mononucleosis. NEnglJ Med 1979; 301:1133-7.
6. YAO QY, RICKINSON AB, EPSTEIN MA: A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 1985; 35: 35-42.
7. GARZELLI C: Epstein-Barr Virus and autoimmunity. In FRIEDMAN H, ROSE NR, and BENDINELLIM (Eds.): Microorganisms and Autoimmune Diseases. New York, Plenum Press, 1996: 197-217.
8. FOX RI, LUPPI M, PISA P, KANG HI: Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J Rhciimatol 1992; 19 (S32): 18-24.
9. SCULLEY DG, SCULLEY TB, POPE JH: Reactions of sera from patients with rheumatoid arthritis, systemic lupus erytematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides. .7 Gen V7ro/1986; 67: 2253-8.
10. ALLAWAY GP, SRINIVASAPPA J, MILLER FW, PRABHAKAR BS, NOTKINS AL: Spontaneously proliferating human B lymphocytes make autoantibodies.J/H/ecrDù 1988;157: 968-72.
11. HENLE W, HENLE G, ANDERSSON J et al.: Antibody responses to Epstein-Barr virusdetermined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.ProcNatlAcadSciVSA 1987; 84:570-4.
12. BENCIVELLI W, VITALI C, ISENBERG D, SMOLEN J, SNAITH M, SCIUTO M: Disease activity in systemic lupus crythematosus: Report of the consensus study group of the European Workshop for Rheumathology Research. Clin Exp Rheumatol 1997; 10: 54954.
13. PEDNEAULT L, KATZ BZ: Comparison of the polymerase chain reaction and standard southern blotting for the detection of EpsteinBarr virus DNA in various biopsy specimens. J Mcd Virol 1993; 39: 33-43.
14. IIOPP TP, WOODS R: Prediction of protein antigenic determinants from aminoacid se-quences. Proc Nail Acad Sei USA 1981;78: 3824-8.
15. ATHERTON E, LOGAN CJ, SHEPPARD RC: Peptide synthesis. Part 2. Procedure for solid phase synthesis using N-a-fluorenylmethoxycarbonyl aminoacids on polyamide supports. Synthesis of substance P and acyl carrier 65-74 decapeptide. J ChemSoc 1981; 1: 538-56.
16. SABBATINI A, DOLCHER MP, MARCHINI B, BOMBARDIERIS, MIGLIORINIP: Mapping of epitopes on the SmD molecule: The use of multiple antigen peptide to measure autoantibodies in systemic lupus erythematosus. J Rlieitmatol 1993; 20:1679-83.
17. DEPPER JM, ZVAIFLER NJ, BLUESTEIN HG: Oropharyngeal Epstein-Barr virus excretion in rheumatoid arthritis. Arthritis Rheum 1982; 25:42731.
18. AITCHESON CT, WILSON GL, FERRELL PB, TAN EM: Frequency of transforming EpsteinBarr virus in Oropharyngeal secretions of rheumatoid arthritis patients. Intervirology 1983; 19: 135-43.
19. MYLES AB, DALY JR: Side-effects of corticosteroid treatment. In MYLES AB and DALY JR (Eds.): Corticostcroid and AcTH Treatment. Principles and Problems. London, Edward Arnold 1974:182-204.
20. TSOKOS GC, BALOW JE: Cellular immune responses in systemic lupus erythematosus. Prog Allergy 1984; 35: 93-161.
21. TSOKOS GC, MAGRATH IT, BALOW JE: Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol 1983; 131: 17971801.
22. SABBATINI A, BOMBARDIERI S, MIGLIORINI P: Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA 1. Eur J Immunol 1993; 23:1146-52.
23. RHODES G, RUMPOLD H, KURKI P, PATRICK KM, CARSON DA, VAUGHAN JH: Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. JExpMed 1987; 165: 1026-40.
24. VAUGIIAN JH, VALBRACHT JR, NGUYEN MD, IIANDLEY HH, SMITH RS, PATRICK K, RHODES GH: Epstein-Barr virus induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 1995; 95: 1306-15.
25. VAUGHAN JH, NGUYEN M-D, VALBRACHT JR, PATRICK K, RHODES GH: Epstein-Barr virus induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and not mimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995; 95: 1316-27.
26. STUDIER FW, ROSENBERG AH, DÜNN JJ, DUBENDORFF JW: Use of T7 polymerase to direct expression of cloned genes. Methods Enzy-mol 1990; 85: 60-89.